Sites in Los Angeles and near San Francisco California are enrolling people with severe SCD for a trial to test a gene ...

Columnist Sylvia Amuta works to manage her anxiety after noticing that her own stress has a negative impact on her cousin ...

Columnist Oluwatosin Adesoye addresses some of the myths about blood transfusion and explains why it's important in managing ...

Cyclosporin H boosts a new lentivirus-delivered gene therapy with enhanced anti-sickling properties in blood stem cells from ...

Digital cognitive behavioral therapy was as effective as pain education at easing sickle cell pain, a study reported.

Too many people with sickle cell disease are dying preventable deaths. This negligence must end, columnist Mary Shaniqua says ...

The Clinton Health Access Initiative (CHAI) is leading a project that aims to expand access to diagnostic tests and treatments for sickle cell disease (SCD). The project is being funded by a ...

I recently wrote about my disappointment regarding Pfizer’s decision to withdraw Oxbryta (voxelotor) from global markets as a treatment option for sickle cell disease. Therefore, it seems only fitting ...